WEBINAR: Implementation of HIV Management Guidelines: TLD vs TEE (08 June - 14:00)

[Knowledge Hub]

 <https://us02web.zoom.us/webinar/register/WN_s6scDwyGRkS74-mu1zdqZw> 


 

Implementation of HIV Management Guidelines: TLD vs TEE

08 June 2022, 14:00 - 16:00

 

The 2020 South African HIV Management Guidelines recommend the use of the
dolutegravir-based regimens as the preferred first-line and second-line
treatment for all populations, including pregnant women and those of
childbearing potential. Integrase inhibitors such as dolutegravir have many
advantages over their non-nucleoside reverse-transcriptase inhibitor (NNTRI)
counterparts such as efavirenz - better tolerability and fewer side-effects,
better efficacy, low cost, and a high genetic barrier to resistance. However
controversies associated with dolutegravir may have hindered its uptake. 

 

This webinar aims to clarify any conflicting information, share evidence
that will improve the confidence of healthcare providers to initiate ARV
regimens as per National Clinical Guidelines, improve communication and
client counselling, including: 

*	Initiation of stable adults patient on DTG
*	TB/HIV co-infection and DTG
*	Pregnancy and DTG
*	Paediatrics and DTG
*	Transition to DTG: 1st line vs 2nd line
*	Side effects/drug-drug interaction of DTG 

 

 <https://us02web.zoom.us/webinar/register/WN_s6scDwyGRkS74-mu1zdqZw> 

 

https://us02web.zoom.us/webinar/register/WN_s6scDwyGRkS74-mu1zdqZw 

 

Once you have registered, you will receive a confirmation email with details
on how to join the webinar.

 

Please share the registration link above with colleagues and your network.

 



We look forward to engaging with you at the webinar.

 

For queries or technical assistance, please email info at knowledgehub.org.za
<mailto:info at knowledgehub.org.za> .

 

Regards,

 

NDOH Knowledge Hub Team

https://www.knowledgehub.org.za <https://www.knowledgehub.org.za/>  

 

 

You are receiving this email because you are subscribed to the Knowledge Hub
Mailing List.

If you do not want to receive any further emails, please
<https://protect-za.mimecast.com/s/-bshCg5K6AHlz3wpT2DQxO?domain=mailman.kno
wledgehub.org.za> unsubscribe here.

 
<https://protect-za.mimecast.com/s/r93yC0gpO5F2AxgZtDBPd7?domain=knowledgehu
b.org.za/> 

 

 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mailman.knowledgehub.org.za/pipermail/information/attachments/20220601/30baf617/attachment.htm>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 329506 bytes
Desc: not available
URL: <http://mailman.knowledgehub.org.za/pipermail/information/attachments/20220601/30baf617/attachment.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image002.png
Type: image/png
Size: 6386 bytes
Desc: not available
URL: <http://mailman.knowledgehub.org.za/pipermail/information/attachments/20220601/30baf617/attachment-0001.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image003.png
Type: image/png
Size: 20115 bytes
Desc: not available
URL: <http://mailman.knowledgehub.org.za/pipermail/information/attachments/20220601/30baf617/attachment-0002.png>